“World Health” reveals the effectiveness of drugs to treat “Corona”

10:00 AM

Saturday 17 October 2020

–

A clinical study conducted by the World Health Organization concluded that the “remdesivir” treatment does not significantly affect the chances of survival of “Covid 19” patients, in a major blow to the hopes pinned on the use of available drugs in the face of the epidemic.

According to the Financial Times, the study looked at the effects of remdesivir and three other potential drug regimens on 11,266 patients who received hospital care, and concluded that none of the four treatments significantly affected the risk of death or affected the patients ’need. For breathing apparatus.

The study found that “the remdesivir, hydroxychloroquine, lopinavir, and interferon regimens seem to have a negligible effect on in-hospital Covid-19 deaths.”

The results of the WHO trial also showed that the drugs had little effect on how long patients stayed in the hospital. However, the researchers said the study was primarily designed to assess the effect on in-hospital deaths. The study has yet to be peer-reviewed, according to Sputnik.

Remdesivir was one of a group of drugs used to treat US President Donald Trump, after it was tested positive for Covid-19, a drug being developed by the US company, Gilead Sciences, primarily as a potential drug for treating Ebola.

It received partial approval for use in the United States and the European Union after a trial conducted by the US National Institutes of Health in April showed that it reduced the recovery time from “Covid-19” from 15 days to 11 days.

In July, Gilead released additional data indicating that treatment might reduce the risk of death, but this finding was not confirmed in a randomized controlled trial, the primary criterion for approval of the drug.

– .